LONDON – April 7, 2015 – Sabin Foundation Europe, the UK partner of the Sabin Vaccine Institute (Sabin), today announced the appointment of Mr. John Cummins, Group Treasurer of the Royal Bank of Scotland, as chairman of Sabin Foundation Europe (SFE), and the election of Rt Hon Baroness Helene Hayman GBE, a member of the UK Parliament’s House of Lords, to the SFE Board of Trustees. Mr. Cummins has served on the SFE Board of Trustees since January 2013. Baroness Hayman has served on the Sabin Board of Trustees since July 2011 and will continue to do so as she joins the SFE Board.

“Mr. Cummins and Baroness Hayman bring extensive experience and expertise to Sabin Foundation Europe. I am confident Mr. Cummins will provide the leadership needed to advance the mission of the Foundation, and I look forward to working closely with him,” said Axel Hoos, MD, PhD, interim chairman of the Sabin Board of Trustees. “We also welcome the news of Baroness Hayman’s appointment to the Foundation’s Board of Trustees. A superb champion of the cause of those suffering from diseases of poverty, Baroness Hayman will continue to lend her strong voice as we work together to combat vaccine-preventable and neglected tropical diseases.”

Sabin Foundation Europe, in partnership with the Sabin Vaccine Institute based in Washington, D.C., promotes proven, cost-effective solutions to the world’s most pervasive, and often neglected health issues. It works to raise awareness and funding, particularly in the United Kingdom and across Europe, to combat vaccine-preventable and neglected tropical diseases. These diseases primarily afflict the world’s poorest people — those living on less than US $1.25 per day — whose health and economic well-being are often severely impacted.

Prior to joining the Royal Bank of Scotland, Mr. Cummins served as a member of the Board of Directors of the International Finance Facility for Immunisation Company (IFFIm), which has raised more than US $5 billion for vaccines for low-income countries. He holds a Master of Arts in Modern History from Oxford University and a Master of Business Administration from Bradford University.

“It has been a privilege to serve on the Foundation’s Board of Trustees over the past two years,” said Mr. Cummins. “As chairman, I hope to build on the progress we have made in ensuring global health investments remain a priority for the UK and EU governments.”

The SFE Board also elected Baroness Hayman as a new trustee. Baroness Hayman is the vice-chair of the All Party Parliamentary Group on Malaria and Neglected Tropical Diseases. Baroness Hayman began her parliamentary career in the House of Commons in 1974 as an elected member of parliament, and became a life peer in 1996. She has dedicated the last 40 years to public service and served as a Government Minister of State and the first elected Lord Speaker of the House of Lords, the upper chamber of the UK Parliament (2006–2011). Outside of her career in politics, she has been the chair of the Whittingdon Hospital NHS Trust, chair of Cancer Research UK and the former chair of the Human Tissue Authority. She is currently chair of Cambridge University Health Partners.

“I am proud to serve on the Board of Trustees of the Sabin Vaccine Institute and Sabin Foundation Europe as we work toward meeting the health needs of those most vulnerable,” said Baroness Hayman. “Through our advocacy for helping the world’s most marginalized communities and working to collaborate across sectors, we will help end this needless suffering and provide pathways out of poverty.”

Baroness Hayman joins current Sabin Foundation Europe Board of Trustees: Mr. Cummins, chairman of Sabin Foundation Europe; Mr. Jeremy Lefroy, Member of Parliament, UK House of Commons and chair of the All Party Parliamentary Group on Malaria and NTDs; and Mr. James Beery, Senior of Counsel in Covington & Burling’s London office.



About the Sabin Foundation Europe

Sabin Foundation Europe is a UK-registered charity founded in 2011 to support vaccine research and development, advocacy efforts and treatment programmes for vaccine-preventable and neglected tropical diseases. As a partner of the U.S.-based Sabin Vaccine Institute, Sabin Foundation Europe leads the efforts in the United Kingdom and across Europe to promote proven, cost-effective solutions to the world’s most pervasive, and least understood, health issues to policymakers, partners and other institutions. For more information, please visit

About the Sabin Vaccine Institute

The Sabin Vaccine Institute (Sabin) is a non-profit, 501(c)(3) organization of scientists, researchers and advocates dedicated to reducing needless human suffering from vaccine-preventable and neglected tropical diseases (NTDs). Since its founding in 1993 in honor of Dr. Albert B. Sabin, the developer of the oral polio vaccine, Sabin has been at the forefront of global efforts to eliminate, prevent, and cure infectious and neglected tropical diseases.

Sabin develops new vaccines, advocates for increased use of existing vaccines and promotes expanded access to affordable medical treatments in collaboration with governments, academic institutions, scientists, medical professionals and other non-profit organizations. For more information, please visit

Media Contact
Kelly Toves
+1 (202) 621-1691